betadex and Diabetes-Mellitus

betadex has been researched along with Diabetes-Mellitus* in 2 studies

Other Studies

2 other study(ies) available for betadex and Diabetes-Mellitus

ArticleYear
Fabrication of carboxymethylcellulose hydrogel containing β-cyclodextrin-eugenol inclusion complexes for promoting diabetic wound healing.
    Journal of biomaterials applications, 2020, Volume: 34, Issue:6

    Topics: Animals; Antioxidants; beta-Cyclodextrins; Carboxymethylcellulose Sodium; Cyclodextrins; Diabetes Mellitus; Drug Carriers; Drug Liberation; Eugenol; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Hydrogels; Inflammation; Mice, Inbred C57BL; NF-kappa B; Receptors, Lipoprotein; Vascular Endothelial Growth Factor A; Wound Healing

2020
Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients.
    Diabetes, 2014, Volume: 63, Issue:4

    Peroxynitrite (ONOO(-)) contributes to coronary microvascular dysfunction in diabetes mellitus (DM). We hypothesized that in DM, ONOO(-) interferes with the function of coronary endothelial caveolae, which plays an important role in nitric oxide (NO)-dependent vasomotor regulation. Flow-mediated dilation (FMD) of coronary arterioles was investigated in DM (n = 41) and non-DM (n = 37) patients undergoing heart surgery. NO-mediated coronary FMD was significantly reduced in DM patients, which was restored by ONOO(-) scavenger, iron-(III)-tetrakis(N-methyl-4'pyridyl)porphyrin-pentachloride, or uric acid, whereas exogenous ONOO(-) reduced FMD in non-DM subjects. Immunoelectron microscopy demonstrated an increased 3-nitrotyrosine formation (ONOO(-)-specific protein nitration) in endothelial plasma membrane in DM, which colocalized with caveolin-1 (Cav-1), the key structural protein of caveolae. The membrane-localized Cav-1 was significantly reduced in DM and also in high glucose-exposed coronary endothelial cells. We also found that DM patients exhibited a decreased number of endothelial caveolae, whereas exogenous ONOO(-) reduced caveolae number. Correspondingly, pharmacological (methyl-β-cyclodextrin) or genetic disruption of caveolae (Cav-1 knockout mice) abolished coronary FMD, which was rescued by sepiapterin, the stable precursor of NO synthase (NOS) cofactor, tetrahydrobiopterin. Sepiapterin also restored coronary FMD in DM patients. Thus, we propose that ONOO(-) selectively targets and disrupts endothelial caveolae, which contributes to NOS uncoupling, and, hence, reduced NO-mediated coronary vasodilation in DM patients.

    Topics: Aged; Animals; Arterioles; beta-Cyclodextrins; Caveolae; Caveolin 1; Cells, Cultured; Diabetes Mellitus; Endothelial Cells; Endothelium, Vascular; Female; Humans; Male; Mice; Mice, Knockout; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Pterins; Regional Blood Flow; Tyrosine; Vasodilation

2014